Effects of Global SGLT2 Knockout on Heart Failure with Preserved Ejection Fraction

被引：0
|
作者：
Fain, Margaret E. [1 ]
Misener, Sol [1 ]
Zhou, Yalu [1 ]
Rousselle, Thomas [2 ]
Mas, Valeria R. [2 ]
Quaggin, Susan E. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] Univ Maryland, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024sr4k42qt
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO278
引用
收藏
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF SGLT2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Cohen, Laura
    Isaza, Nicolas
    Hernandez, Inmaculada
    Lewis, Gregory D.
    Ho, Jennifer
    Fonarow, Gregg C.
    Kazi, Dhruv
    Bellows, Brandon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 285 - 285
  • [22] SGLT2 inhibitors in real-world patients with heart failure with preserved ejection fraction
    Tarantini, R.
    Vecchi, A. L.
    Matteo, F.
    De Ponti, R.
    Mortara, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 779 - 779
  • [23] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Uday Sankar Das
    Aritra Paul
    Suvro Banerjee
    The Egyptian Heart Journal, 73
  • [24] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Das, Uday Sankar
    Paul, Aritra
    Banerjee, Suvro
    EGYPTIAN HEART JOURNAL, 2021, 73 (01):
  • [25] Emerging concepts in heart failure management and treatment: focus on SGLT2 inhibitors in heart failure with preserved ejection fraction
    De Lorenzi, Andrea Beatriz
    Kaplinsky, Edgardo
    Zambrano, Marx Rivera
    Chaume, Laia Tomas
    Rosas, Joan Monell
    DRUGS IN CONTEXT, 2023, 12 : 1 - 16
  • [26] SGLT2 inhibition in heart failure with reduced or preserved ejection fraction: Finding the right patients to treat
    Girerd, Nicolas
    Zannad, Faiez
    JOURNAL OF INTERNAL MEDICINE, 2023, 293 (05) : 550 - 558
  • [27] SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study
    Lu, He
    Shang, Pingping
    Zhou, Dexing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [28] Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction
    Selvaraj, Senthil
    Patel, Shachi
    Sauer, Andrew J.
    Mcgarrah, Robert W.
    Jones, Philip
    Kwee, Lydia Coulter
    Windsor, Sheryl L.
    Ilkayeva, Olga
    Muehlbauer, Michael J.
    Newgard, Christopher B.
    Borlaug, Barry A.
    Kitzman, Dalane W.
    Shah, Sanjiv J.
    Margulies, Kenneth B.
    Husain, Mansoor
    Inzucchi, Silvio E.
    Mcguire, Darren K.
    Lanfear, David E.
    Javaheri, Ali
    Umpierrez, Guillermo
    Mentz, Robert J.
    Sharma, Kavita
    Kosiborod, Mikhail N.
    Shah, Svati H.
    CIRCULATION-HEART FAILURE, 2024, 17 (11)
  • [29] SGLT2 inhibitors are associated with development of heart failure with improved ejection fraction
    Yang, C. D.
    Wang, X. Q.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [30] SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?
    Raschi, Emanuel
    Fadini, Gian Paolo
    Diemberger, Igor
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (05) : 647 - 650
12345